← Embecta Corp.
| Annual Trend | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|
| Revenues | $1.1b |
$1.2b
+7.35%
|
$1.1b
-3.07%
|
$1.1b
-0.77%
|
$1.1b
+0.21%
|
$1.1b
-3.80%
|
$1.0b
-5.71%
|
|
| Cost of products sold | $322.9m |
$364.9m
+13.01%
|
$354.6m
-2.82%
|
$370.9m
+4.60%
|
$387.9m
+4.58%
|
$403.6m
+4.05%
|
— | |
| Gross Profit | $762.6m |
$800.4m
+4.96%
|
$774.9m
-3.19%
|
$749.9m
-3.23%
|
$735.2m
-1.96%
|
$676.8m
-7.94%
|
$601.3m
-11.16%
|
|
| Research and development expense | $61.4m | $63.3m | $66.9m | $85.2m | $78.8m | $37.3m | $20.2m | |
| Other operating expenses | $0 | $4.8m | $44.7m | $99.4m | $124.5m | $65.4m | — | |
| Total Operating Expenses | $276.1m | $308.4m | $465.3m | $528.4m | $568.4m | $434.7m | $353.5m | |
| Operating Income | $486.5m |
$492.0m
+1.13%
|
$309.6m
-37.07%
|
$221.5m
-28.46%
|
$166.8m
-24.70%
|
$242.1m
+45.14%
|
$247.8m
+2.35%
|
|
| Interest expense, net | $0 | $0 | ($46.2m) | ($107.0m) | ($112.3m) | ($107.3m) | $96.7m | |
| Other income (expense), net | ($700k) | $2.9m | ($6.8m) | ($8.8m) | ($10.3m) | $1.5m | ($26.1m) | |
| Income Before Income Taxes | $485.8m | $494.9m | $256.6m | $105.7m | $44.2m | $136.3m | $125.0m | |
| Income tax provision (benefit) | $58.2m | $80.1m | $33.0m | $35.3m | ($34.1m) | $40.9m | — | |
| Net Income | $427.6m |
$414.8m
-2.99%
|
$223.6m
-46.09%
|
$70.4m
-68.52%
|
$78.3m
+11.22%
|
$95.4m
+21.84%
|
$87.5m
-8.28%
|
|
| Basic (in dollars per share) | $7.50 | $7.28 | $3.92 | $1.23 | $1.36 | $1.64 | — | |
| Diluted (in dollars per share) | $7.50 | $7.28 | $3.89 | $1.22 | $1.34 | $1.62 | — | |
| Selling and administrative expense | $214.7m | $240.3m | $294.8m | $341.3m | $365.1m | $332.0m | — | |
| Impairment expense | $0 | $0 | $58.9m | $2.5m | $0 | $0 | — |
Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.